| 1 |
Kang J，Yao W，Cai B，et al.Current situation of asthma-COPD overlap syndrome (ACOS)in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter，cross-sectional trial (study protocol)[J]．J Thorac Dis，2016，8(12)：3744-3751.
|
| 2 |
Gibson PG，Simpson JL.The overlap syndrome of asthma and COPD：what are its features and how important is it？[J]．Thorax，2009，64(8)：728-735.
|
| 3 |
Lau EMT，Roche NA，Reddel HK.Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap[J]．Expert Rev Clin Immunol，2017，13(5)：449-455.
|
| 4 |
Leung JM，Sin DD.Asthma-COPD overlap syndrome: pathogenesis，clinical features，and therapeutic targets[J]．BMJ，2017(358)：j3772.
|
| 5 |
Redefining the overlap of asthma and COPD[J]．Drug Ther Bull，2017，55(7)：66-69.
|
| 6 |
Parisi CAS，Zunino S，Las Heras M，et al.The epidemiology of asthma in adults[J]．Rev Alerg Mex，2020，67(4)：397-400.
|
| 7 |
Abramson MJ，Perret JL，Dharmage SC，et al.Distinguishing adult-onset asthma from COPD：a review and a new approach[J]．Int J Chron Obstruct Pulmon Dis，2014(9)：945-962.
|
| 8 |
Chung JW，Kong KA，Lee JH，et al.Characteristics and self-rated health of overlap syndrome[J]．Int J Chron Obstruct Pulmon Dis，2014(9)：795-804.
|
| 9 |
Menezes AMB，Montes de Oca M，Pérez-Padilla R，et al.Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype：COPD-asthma[J]．Chest，2014，145(2)：297-304.
|
| 10 |
Chung WS，Lin CL，Kao CH.Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients：a population-based cohort study[J]．Medicine (Baltimore)，2015，94(17)：e755.
|
| 11 |
Wurst KE，Rheault TR，Edwards L，et al.A comparison of COPD patients with and without ACOS in the ECLIPSE study[J]．Eur Respir J，2016，47(5)：1559-1562.
|
| 12 |
van Boven JF，Román-Rodríguez M，Palmer JF，et al.Comorbidome，pattern，and impact of asthma-COPD overlap syndrome in real life[J]．Chest，2016，149(4)：1011-1020.
|
| 13 |
Kumbhare S，Pleasants R，Ohar JA，et al.Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the united states[J]．Ann Am Thorac Soc，2016，13(6)：803-810.
|
| 14 |
Sorino C，Scichilone N，D’Amato M，et al.Asthma-COPD overlap syndrome：recent advances in diagnostic criteria and prognostic significance[J]．Minerva Med，2017，108(3 Suppl 1)：1-5.
|
| 15 |
Morgan BW，Grigsby MR，Siddharthan T，et al.Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low-and middle-income countries[J]．J Allergy Clin Immunol，2019，143(4)：1598-1606.
|
| 16 |
Duong-Quy S，Tran Van H，Vo Thi Kim A，et al.Clinical and functional characteristics of subjects with asthma，COPD，and asthma-COPD overlap：a multicentre study in vietnam[J]．Can Respir J，2018(2018)：1732946.
|
| 17 |
Kao YH，Tseng TS，Ng YY，et al.Association between continuity of care and emergency department visits and hospitalization in senior adults with asthma-COPD overlap[J]．Health Policy，2019，123(2)：222-228.
|
| 18 |
To T，Zhu J，Larsen K，et al.Progression from asthma to chronic obstructive pulmonary disease.is air pollution a risk factor？[J]．Am J Respir Crit Care Med，2016，194(4)：429-438.
|
| 19 |
Oh JY，Lee YS，Min KH，et al.Increased urinary l-histidine in patients with asthma-COPD overlap：a pilot study[J]．Am J Respir Crit Care Med，2018(13)：1809-1818.
|
| 20 |
Sin DD，Miravitlles M，Mannino DM，et al.What is asthma-COPD overlap syndrome? towards a consensus definition from a round table discussion[J]．Eur Respir J，2016，48(3)：664-673.
|
| 21 |
Guo Y，Hong C，Liu Y，et al.Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome[J]．Medicine (Baltimore)，2018，97(23)：e10857.
|
| 22 |
Jo YS，Kwon SO，Kim J，et al.Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap[J]．J Thorac Dis，2018，10(8)：5047-5056.
|
| 23 |
Shirai T，Hirai K，Gon Y，et al.Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap[J]．J Allergy Clin Immunol Pract，2019，7(1)：134-145.
|
| 24 |
Huang X，Tan X，Liang Y，et al.Differential DAMP release was observed in the sputum of COPD，asthma and asthma-COPD overlap(ACO)patients[J]．Sci Rep，2019，9(1)：19241.
|
| 25 |
Kondo M，Tamaoki J．Therapeutic approaches of asthma and COPD overlap[J]．Allergol Int，2018，67(2)：187-190.
|
| 26 |
Lim HS，Choi SM，Lee J，et al.Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome[J]．Ann Allergy Asthma Immunol，2014，113(6)：652-657.
|
| 27 |
Feng JX，Lin Y，Lin J，et al.Relationship between fractional exhaled nitric oxide level and efficacy of inhaled corticosteroid in asthma-COPD overlap syndrome patients with different disease severity[J]．J Korean Med Sci，2017，32(3)：439-447.
|
| 28 |
Xu H，Lu X．Inhaled glucocorticoid with or without tiotropium bromide for asthma-chronic obstructive pulmonary disease overlap syndrome[J]．J Coll Physicians Surg Pak，2019，29(3)：249-252.
|
| 29 |
Nixon J，Newbold P，Mustelin T，et al.Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation[J]．Pharmacol Ther，2017(169)：57-77.
|
| 30 |
Varricchi G，Bagnasco D，Borriello F，et al.Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders：evidence and unmet needs[J]．Curr Opin Allergy Clin Immunol，2016，16(2)：186-200.
|
| 31 |
Ortega HG，Liu MC，Pavord ID，et al.Mepolizumab treatment in patients with severe eosinophilic asthma[J]．N Engl J Med，2014，371(13)：1198-207.
|
| 32 |
Bel EH，Wenzel SE，Thompson PJ，et al.Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma[J]．N Engl J Med，2014，371(13)：1189-1197.
|
| 33 |
Brightling CE，Bleecker ER，Panettieri RA Jr，et al.Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia：a randomised，double-blind，placebo-controlled，phase 2a study[J]．Lancet Respir Med，2014，2(11)：891-901.
|
| 34 |
Wenzel S，Ford L，Pearlman D，et al.Dupilumab in persistent asthma with elevated eosinophil levels[J]．N Engl J Med，2013，368(26)：2455-2466.
|
| 35 |
Hanania NA，Noonan M，Corren J，et al.Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies[J]．Thorax，2015，70(8)：748-756.
|
| 36 |
Song CH，Lee JK.Lebrikizumab treatment in adults with asthma[J]．N Engl J Med，2011，365(25)：2433.
|
| 37 |
Brightling CE，Chanez P，Leigh R，et al.Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma：a randomised，double-blind，placebo-controlled，phase 2b trial[J]．Lancet Respir Med，2015，3(9)：692-701.
|
| 38 |
Izuhara K，Ohta S，Ono J，et al.Using periostin as a biomarker in the treatment of asthma[J]．Allergy Asthma Immunol Res，2016，8(6)：491-498.
|
| 39 |
Barnes PJ.Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes[J]．J Allergy Clin Immunol，2015，136(3)：531-545.
|
| 40 |
Kostadima E，Tsiodras S，Alexopoulos EI，et al.Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma[J]．Eur Respir J，2004，23(5)：714-717.
|
| 41 |
Kew KM，Undela K，Kotortsi I，et al.Macrolides for chronic asthma[J]．Cochrane Database Syst Rev，2015(9)：CD002997.
|
| 42 |
Lee SY，Park HY，Kim EK，et al.Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome[J]．Int J Chron Obstruct Pulmon Dis，2016(11)：2797-2803.
|
| 43 |
Aparicio González T．Tiotropium in asthma poorly controlled with standard combination therapy[J]．Rev Clin Esp (Barc)，2013，213(2)：115.
|
| 44 |
Szefler SJ，Murphy K，Harper T 3rd，et al.A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma[J]．J Allergy Clin Immunol，2017，140(5)：1277-1287.
|
| 45 |
Hamelmann E，Bernstein JA，Vandewalker M，et al.A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma[J]．Eur Respir J，2017，49(1)：1601100.
|
| 46 |
Kerstjens HA，Moroni-Zentgraf P，Tashkin DP，et al.Tiotropium improves lung function，exacerbation rate，and asthma control，independent of baseline characteristics including age，degree of airway obstruction，and allergic status[J]．Respir Med，2016(117)：198-206.
|
| 47 |
Kerstjens HA，Casale TB，Bleecker ER，et al.Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma：two replicate，double-blind，placebo-controlled，parallel-group，active-comparator，randomised trials[J]．Lancet Respir Med，2015，3(5)：367-376.
|
| 48 |
Peters SP，Kunselman SJ，Icitovic N，et al.Tiotropium bromide step-up therapy for adults with uncontrolled asthma[J]．N Engl J Med，2010，363(18)：1715-1726.
|
| 49 |
Yeh JJ，Lin CL，Hsu CY，et al.Associations between statins and coronary artery disease and stroke risks in patients with asthma-chronic obstructive pulmonary disease overlap syndrome：a time-dependent regression study[J]．Atherosclerosis，2019(283)：61-68.
|
| 50 |
Yeh JJ，Syue SH，Lin CL，et al.Effects of statins on anxiety and depression in patients with asthma-chronic obstructive pulmonary disease overlap syndrome[J]．J Affect Disord，2019(253)：277-284.
|